Proteopedia:Featured SEL/1
From Proteopedia
(Difference between revisions)
(image must be a link) |
|||
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
<table> | <table> | ||
| - | <tr><td> | + | <tr><td> |
| + | <imagemap> | ||
| + | Image:Anim Avian Influenza Neuraminidase.gif | ||
| + | default [[Avian_Influenza_Neuraminidase,_Tamiflu_and_Relenza]] | ||
| + | </imagemap> | ||
| + | </td></tr> | ||
<tr><td><div class='scrolling'>'''Avian Influenza Neuraminidase'''<br> | <tr><td><div class='scrolling'>'''Avian Influenza Neuraminidase'''<br> | ||
''Eric Martz''<br> | ''Eric Martz''<br> | ||
| - | + | The first new influenza virus to emerge as an imminent pandemic threat in the 21st century is H1N1 swine flu. The drug '''oseltamivir''' (Tamiflu®) inhibits flu neuraminidase, a component necessary for virus spread, in susceptible flu strains. The development of oseltamivir was guided, in part, by crystallographically determined structures of flu neuraminidase, which is a homotetramer, shown with oseltamivir bound. Oseltamivir was designed to fit N2/N9 (neuraminidases from other strains of flu). Serendipitously, it also fits N1 by induced fit. | |
| + | |||
| + | >>> [[Avian_Influenza_Neuraminidase%2C_Tamiflu_and_Relenza|Visit this page]] >>> | ||
</div> | </div> | ||
</td></tr> | </td></tr> | ||
</table> | </table> | ||
| + | |||
| + | [[Category:Featured in Selected Pages]] | ||
Current revision
  |
Avian Influenza Neuraminidase
Eric Martz >>> Visit this page >>> |
